A Phase I, Randomized, Placebo-Controlled, Double Blind, Trial of Safety, Tolerabilityand Efficacy Study of Topical AKP-11 Administration to Participants with Arthritis.
Phase of Trial: Phase I
Latest Information Update: 10 Feb 2017
At a glance
- Drugs AKP 11 (Primary)
- Indications Gout; Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Akaal Pharma
- 09 Feb 2017 Status changed from recruiting to completed.
- 15 Aug 2016 Status changed from not yet recruiting to recruiting.
- 15 Jul 2016 New trial record